From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
Open Access
- 9 May 2023
- journal article
- editorial
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 29, 347-349
Abstract
No abstract availableFunding Information
- National Human Genome Research Institute (1ZIAHG200318-16)
This publication has 9 references indexed in Scilit:
- Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease IaMolecular Therapy - Methods & Clinical Development, 2023
- Genome editing technologies to treat rare liver diseasesTranslational Gastroenterology and Hepatology, 2020
- Gene therapy for glycogen storage diseasesHuman Molecular Genetics, 2019
- Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type IaHuman Molecular Genetics, 2019
- In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IAMolecular Therapy, 2016
- Vector design influences hepatic genotoxicity after adeno-associated virus gene therapyJournal of Clinical Investigation, 2015
- Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleasesNucleic Acids Research, 2011
- Episomal Persistence of Recombinant Adenoviral Vector Genomes during the Cell Cycle In VivoJournal of Virology, 2003
- GeneReviews®1993